George K. Ng
Chief Executive Officer, Director · Processa Pharmaceuticals, Inc.
- 2024
- Aug 11, 2026
- 13
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies George K. Ng files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Russell Skibsted - $42K in PCSA purchases and sales in the last 12 months
- Wendy Guy - $33K in PCSA purchases and sales in the last 12 months
- David Young - $32K in PCSA purchases and sales in the last 12 months
- Patrick Lin - $28K in PCSA purchases and sales in the last 12 months
- Sian Bigora - $21K in PCSA purchases and sales in the last 12 months
- Khoso Baluch - $6K in PCSA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is George K. Ng?
George K. Ng is a corporate insider, tracked as Chief Executive Officer, Director of Processa Pharmaceuticals, Inc. (PCSA). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has George K. Ng submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has George K. Ng been buying or selling stock?
Recorded transactions: 7 open-market purchases ($39K) and 0 open-market sales across all tracked filings.
